StockNews.com Begins Coverage on Rocket Pharmaceuticals (NASDAQ:RCKT) : vimarsana.com

Research analysts at StockNews.com initiated coverage on shares of Rocket Pharmaceuticals (NASDAQ:RCKT – Get Rating) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. A number of other analysts have also recently issued reports on the company. William Blair reiterated an “outperform” […]

Related Keywords

John Militello , William Blair , Institutional Trading Of Rocket Pharmaceuticals , Clearstead Advisors , Morgan Stanley , Rocket Pharmaceuticals Stock , Great West Life Assurance Co , News Ratings For Rocket Pharmaceuticals Daily , Rocket Pharmaceuticals Inc , Rocket Pharmaceuticals , Advisor Group Holdings Inc , Insider Transactions At Rocket Pharmaceuticals , Needham Company , Securities Exchange Commission , Analyst Recommendations For Rocket Pharmaceuticals , Allspring Global Investments Holdings , Steward Partners Investment Advisory , Get Rating , Exchange Commission , Global Investments Holdings , Group Holdings , Partners Investment Advisory , Great West Life Assurance , Rocket Pharmaceuticals Daily , Nasdaq Rckt , Rckt , Medical , Initiated Coverage , Stocknews Com ,